These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21623029)

  • 1. Use of minocycline in viral infections.
    Dutta K; Basu A
    Indian J Med Res; 2011 May; 133(5):467-70. PubMed ID: 21623029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Minocycline an Antiviral Agent? A Review of Current Literature.
    Nagarakanti S; Bishburg E
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):4-8. PubMed ID: 26177421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.
    Mishra MK; Basu A
    J Neurochem; 2008 Jun; 105(5):1582-95. PubMed ID: 18208541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties.
    Garrido-Mesa N; Camuesco D; Arribas B; Comalada M; Bailón E; Cueto-Sola M; Utrilla P; Nieto A; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
    Pharmacol Res; 2011 Apr; 63(4):308-19. PubMed ID: 21193045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and antiviral effects of minocycline in enterovirus 71 infections.
    Liao YT; Wang SM; Chen SH
    Biomed Pharmacother; 2019 Oct; 118():109271. PubMed ID: 31377467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection.
    Bawage SS; Tiwari PM; Pillai S; Dennis VA; Singh SR
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31405261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline but not tigecycline is neuroprotective and reduces the neuroinflammatory response induced by the superimposition of sepsis upon traumatic brain injury.
    Adembri C; Selmi V; Vitali L; Tani A; Margheri M; Loriga B; Carlucci M; Nosi D; Formigli L; De Gaudio AR
    Crit Care Med; 2014 Aug; 42(8):e570-82. PubMed ID: 24810523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
    Labro MT
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):319-40. PubMed ID: 22397566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is behind the non-antibiotic properties of minocycline?
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Pharmacol Res; 2013 Jan; 67(1):18-30. PubMed ID: 23085382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants: potential antiviral agents for Japanese encephalitis virus infection.
    Zhang Y; Wang Z; Chen H; Chen Z; Tian Y
    Int J Infect Dis; 2014 Jul; 24():30-6. PubMed ID: 24780919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells.
    Szeto GL; Brice AK; Yang HC; Barber SA; Siliciano RF; Clements JE
    J Infect Dis; 2010 Apr; 201(8):1132-40. PubMed ID: 20205570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutraceuticals in Viral Infections: An Overview of the Immunomodulating Properties.
    Costagliola G; Nuzzi G; Spada E; Comberiati P; Verduci E; Peroni DG
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-viral treatment in patients with virus-induced cardiomyopathy.
    Kühl U; Pauschinger M; Poller W; Schultheiss HP
    Ernst Schering Res Found Workshop; 2006; (55):323-42. PubMed ID: 16329670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in antiviral chemotherapy].
    Baba M
    Uirusu; 2005 Jun; 55(1):69-75. PubMed ID: 16308532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 and the resolution of infections.
    Filippi CM; von Herrath MG
    J Pathol; 2008 Jan; 214(2):224-30. PubMed ID: 18161757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viruses, chemotherapy and immunity.
    Koziel MJ; Walker BD
    Parasitology; 1992; 105 Suppl():S85-92. PubMed ID: 1285013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges.
    Singh H; Kakkar AK; Chauhan P
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):997-1003. PubMed ID: 32552044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What clinicians need to know about antiviral drugs and viral resistance.
    Hodinka RL
    Infect Dis Clin North Am; 1997 Dec; 11(4):945-67. PubMed ID: 9421709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.